Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation
- PMID: 15564480
- PMCID: PMC533897
- DOI: 10.1128/JVI.78.24.13708-13716.2004
Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation
Abstract
Proteolytic processing of the dengue virus polyprotein is mediated by host cell proteases and the virus-encoded NS2B-NS3 two-component protease. The NS3 protease represents an attractive target for the development of antiviral inhibitors. The three-dimensional structure of the NS3 protease domain has been determined, but the structural determinants necessary for activation of the enzyme by the NS2B cofactor have been characterized only to a limited extent. To test a possible functional role of the recently proposed Phix(3)Phi motif in NS3 protease activation, we targeted six residues within the NS2B cofactor by site-specific mutagenesis. Residues Trp62, Ser71, Leu75, Ile77, Thr78, and Ile79 in NS2B were replaced with alanine, and in addition, an L75A/I79A double mutant was generated. The effects of these mutations on the activity of the NS2B(H)-NS3pro protease were analyzed in vitro by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of autoproteolytic cleavage at the NS2B/NS3 site and by assay of the enzyme with the fluorogenic peptide substrate GRR-AMC. Compared to the wild type, the L75A, I77A, and I79A mutants demonstrated inefficient autoproteolysis, whereas in the W62A and the L75A/I79A mutants self-cleavage appeared to be almost completely abolished. With exception of the S71A mutant, which had a k(cat)/K(m) value for the GRR-AMC peptide similar to that of the wild type, all other mutants exhibited drastically reduced k(cat) values. These results indicate a pivotal function of conserved residues Trp62, Leu75, and Ile79 in the NS2B cofactor in the structural activation of the dengue virus NS3 serine protease.
Figures
![FIG. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/533897/bin/zjv0240454950001.gif)
![FIG. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/533897/bin/zjv0240454950002.gif)
![FIG. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/533897/bin/zjv0240454950003.gif)
![FIG. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/533897/bin/zjv0240454950004.gif)
![FIG. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/533897/bin/zjv0240454950005.gif)
Similar articles
-
The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development.Antiviral Res. 2015 Jun;118:148-58. doi: 10.1016/j.antiviral.2015.03.014. Epub 2015 Apr 2. Antiviral Res. 2015. PMID: 25842996 Review.
-
Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.Antiviral Res. 2008 Nov;80(2):94-101. doi: 10.1016/j.antiviral.2008.07.001. Epub 2008 Jul 30. Antiviral Res. 2008. PMID: 18674567 Review.
-
The active essential CFNS3d protein complex.FEBS J. 2006 Aug;273(16):3650-62. doi: 10.1111/j.1742-4658.2006.05369.x. FEBS J. 2006. PMID: 16911516
-
Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.Biochem J. 2006 Jul 1;397(1):203-11. doi: 10.1042/BJ20051767. Biochem J. 2006. PMID: 16489931 Free PMC article.
-
Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain.Virology. 1993 Apr;193(2):888-99. doi: 10.1006/viro.1993.1198. Virology. 1993. PMID: 8460492
Cited by
-
Dengue Virus 2 NS2B Targets MAVS and IKKε to Evade the Antiviral Innate Immune Response.J Microbiol Biotechnol. 2023 May 28;33(5):600-606. doi: 10.4014/jmb.2210.10006. Epub 2023 Feb 15. J Microbiol Biotechnol. 2023. PMID: 36788451 Free PMC article.
-
Flavivirus proteases: The viral Achilles heel to prevent future pandemics.Antiviral Res. 2023 Feb;210:105516. doi: 10.1016/j.antiviral.2022.105516. Epub 2022 Dec 29. Antiviral Res. 2023. PMID: 36586467 Free PMC article. Review.
-
A fast-growing dengue virus mutant reveals a dual role of STING in response to infection.Open Biol. 2022 Dec;12(12):220227. doi: 10.1098/rsob.220227. Epub 2022 Dec 14. Open Biol. 2022. PMID: 36514984 Free PMC article.
-
Animal venoms as a source of antiviral peptides active against arboviruses: a systematic review.Arch Virol. 2022 Sep;167(9):1763-1772. doi: 10.1007/s00705-022-05494-8. Epub 2022 Jun 20. Arch Virol. 2022. PMID: 35723756 Review.
-
Identification and In Silico Binding Study of a Highly Potent DENV NS2B-NS3 Covalent Inhibitor.ACS Med Chem Lett. 2022 Mar 8;13(4):599-607. doi: 10.1021/acsmedchemlett.1c00653. eCollection 2022 Apr 14. ACS Med Chem Lett. 2022. PMID: 35450371 Free PMC article.
References
-
- Arias, C. F., F. Preugschat, and J. H. Strauss. 1993. Dengue virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology 193:888-899. - PubMed
-
- Barbato, G., D. O. Cicero, M. C. Nardi, C. Steinkuehler, R. Cortese, R. De Francesco, and R. Bazzo. 1999. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism. J. Mol. Biol. 289:371-384. - PubMed
-
- Bianchi, E., S. Orru, F. Dal Piaz, R. Ingenito, A. Casbarra, G. Biasiol, U. Koch, P. Pucci, and A. Pessi. 1999. Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors. Biochemistry 38:13844-13852. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous